Merit Medical Systems/$MMSI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Merit Medical Systems
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Ticker
$MMSI
Sector
Primary listing
Employees
7,400
Headquarters
Website
MMSI Metrics
BasicAdvanced
$5.5B
46.81
$1.97
0.66
-
Price and volume
Market cap
$5.5B
Beta
0.66
52-week high
$111.45
52-week low
$81.04
Average daily volume
578K
Financial strength
Current ratio
4.092
Quick ratio
2.509
Long term debt to equity
54.453
Total debt to equity
55.143
Interest coverage (TTM)
5.77%
Profitability
EBITDA (TTM)
281.59
Gross margin (TTM)
47.95%
Net profit margin (TTM)
8.31%
Operating margin (TTM)
11.60%
Effective tax rate (TTM)
21.19%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
4.19%
Return on equity (TTM)
8.60%
Valuation
Price to earnings (TTM)
46.811
Price to revenue (TTM)
3.783
Price to book
3.67
Price to tangible book (TTM)
12.98
Price to free cash flow (TTM)
28.573
Free cash flow yield (TTM)
3.50%
Free cash flow per share (TTM)
3.231
Growth
Revenue change (TTM)
10.11%
Earnings per share change (TTM)
-1.88%
3-year revenue growth (CAGR)
8.69%
10-year revenue growth (CAGR)
10.47%
3-year earnings per share growth (CAGR)
25.04%
10-year earnings per share growth (CAGR)
11.60%
What the Analysts think about MMSI
Analyst ratings (Buy, Hold, Sell) for Merit Medical Systems stock.
Bulls say / Bears say
Second quarter revenue jumped 13.2% to $382.5 million, driven by strong demand for the company’s core interventional cardiology and radiology products (Nasdaq)
Non-GAAP operating margin improved to 21.2% from 20.1% year-over-year, showing stronger operational efficiency even with ongoing inflation (GlobeNewswire)
The company raised full-year 2025 revenue guidance to $1.495–$1.507 billion and non-GAAP EPS guidance to $3.52–$3.72, reflecting management’s confidence in continued growth and profitability (GlobeNewswire)
GAAP EPS fell 11.6% year-over-year to $0.54, showing that one-time charges and rising costs affected bottom-line earnings (GlobeNewswire)
GAAP operating margin dropped to 12.3% from 13.6% last year, reflecting pressure from input cost inflation and impacts from shifting trade policies (GlobeNewswire)
Total debt stands at $747.5 million compared to $341.8 million in cash and cash equivalents, leaving net leverage that could limit financial flexibility if growth slows (GlobeNewswire)
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2025.
MMSI Financial Performance
Revenues and expenses
MMSI Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Merit Medical Systems stock?
Merit Medical Systems (MMSI) has a market cap of $5.5B as of September 10, 2025.
What is the P/E ratio for Merit Medical Systems stock?
The price to earnings (P/E) ratio for Merit Medical Systems (MMSI) stock is 46.81 as of September 10, 2025.
Does Merit Medical Systems stock pay dividends?
No, Merit Medical Systems (MMSI) stock does not pay dividends to its shareholders as of September 10, 2025.
When is the next Merit Medical Systems dividend payment date?
Merit Medical Systems (MMSI) stock does not pay dividends to its shareholders.
What is the beta indicator for Merit Medical Systems?
Merit Medical Systems (MMSI) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.